Combination treatment of diabetes with a sodium glucose co-transporter 2 inhibitor (SGLT2) and a glucagon-like peptide-1 receptor agonist (GLP1-RA) appears to also offer protection against heart and kidney… read more.
Rates of coronary heart disease in the UK have declined by about 30% over the past two decades, but this has been offset by rising rates of other… read more.
A new study in Heart Rhythm, the official journal of the Heart Rhythm Society, the Cardiac Electrophysiology Society, and the Pediatric & Congenital Electrophysiology Society, published by Elsevier, examined… read more.
A study in more than 3,000 US counties, with 315 million residents, has suggested that air pollution is linked with stress and depression, putting under-65-year-olds at increased risk… read more.
Women with heart disease are less often treated with cholesterol-lowering drugs than men, according to research presented today at ESC Preventive Cardiology 2024, a scientific congress of the European… read more.
Using a web application to qualify individuals for treatment with a non-prescription statin closely matched the results of clinician assessments in determining a person’s eligibility for taking statins… read more.
Individuals with heart disease stand to gain the most from a low-sodium diet but, on average, consume over twice the recommended daily sodium intake, according to a study… read more.
The drug finasteride, also known as Propecia or Proscar, treats male pattern baldness and enlarged prostate in millions of men worldwide. But a new University of Illinois Urbana-Champaign study suggests… read more.
Men who say they have stressful jobs and also feel they exert high efforts for low reward had double the risk of heart disease compared to men free of those… read more.
There has been a recent three-fold increase in obesity-related deaths from heart disease in the U.S. between 1999 and 2020, according to new research published today in the Journal of… read more.
Patients who feel low when having a cardiac device implanted are more likely to stop taking their heart medications than those without depression, according to research presented today… read more.
An investigator with the University of Kansas School of Pharmacy has filed an invention disclosure, part of a provisional patent application with the United States Patent and Trademark… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
